 Co-Diagnostics NASDAQ:CODX Inc has announced record third-quarter 2021 revenue of 30.1 million, a 38 year-over-year increase, which the company attributed primarily to sales of its Logix Smart coronavirus COVID-19 test. Co-Diagnostics NASDAQ:CODX also recorded a 67.5 increase in its gross profit for the quarter to 26.8 million, representing 89 of consolidated revenue due to improved product mix as compared to the same period last year. 